Polypharmacological Perturbation of the 14-3-3 Adaptor Protein Interactome Stimulates Neurite Outgrowth

Targeting protein-protein interactions (PPIs) is a promising approach in the development of drugs for many indications. 14-3-3 proteins are a family of phosphoprotein-binding molecules with critical functions in dozens of cell signaling networks. 14-3-3s are abundant in the central nervous system, a...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Cell chemical biology Ročník 27; číslo 6; s. 657
Hlavní autori: Kaplan, Andrew, Andrei, Sebastian A, van Regteren Altena, Anna, Simas, Tristan, Banerjee, Sara L, Kato, Nobuo, Bisson, Nicolas, Higuchi, Yusuke, Ottmann, Christian, Fournier, Alyson E
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 18.06.2020
Predmet:
ISSN:2451-9448, 2451-9448
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Targeting protein-protein interactions (PPIs) is a promising approach in the development of drugs for many indications. 14-3-3 proteins are a family of phosphoprotein-binding molecules with critical functions in dozens of cell signaling networks. 14-3-3s are abundant in the central nervous system, and the small molecule fusicoccin-A (FC-A), a tool compound that can be used to manipulate 14-3-3 PPIs, enhances neurite outgrowth in cultured neurons. New semisynthetic FC-A derivatives with improved binding affinity for 14-3-3 complexes have recently been developed. Here, we use a series of screens that identify these compounds as potent inducers of neurite outgrowth through a polypharmacological mechanism. Using proteomics and X-ray crystallography, we discover that these compounds extensively regulate the 14-3-3 interactome by stabilizing specific PPIs, while disrupting others. These results provide new insights into the development of drugs to target 14-3-3 PPIs, a potential therapeutic strategy for CNS diseases.
AbstractList Targeting protein-protein interactions (PPIs) is a promising approach in the development of drugs for many indications. 14-3-3 proteins are a family of phosphoprotein-binding molecules with critical functions in dozens of cell signaling networks. 14-3-3s are abundant in the central nervous system, and the small molecule fusicoccin-A (FC-A), a tool compound that can be used to manipulate 14-3-3 PPIs, enhances neurite outgrowth in cultured neurons. New semisynthetic FC-A derivatives with improved binding affinity for 14-3-3 complexes have recently been developed. Here, we use a series of screens that identify these compounds as potent inducers of neurite outgrowth through a polypharmacological mechanism. Using proteomics and X-ray crystallography, we discover that these compounds extensively regulate the 14-3-3 interactome by stabilizing specific PPIs, while disrupting others. These results provide new insights into the development of drugs to target 14-3-3 PPIs, a potential therapeutic strategy for CNS diseases.
Targeting protein-protein interactions (PPIs) is a promising approach in the development of drugs for many indications. 14-3-3 proteins are a family of phosphoprotein-binding molecules with critical functions in dozens of cell signaling networks. 14-3-3s are abundant in the central nervous system, and the small molecule fusicoccin-A (FC-A), a tool compound that can be used to manipulate 14-3-3 PPIs, enhances neurite outgrowth in cultured neurons. New semisynthetic FC-A derivatives with improved binding affinity for 14-3-3 complexes have recently been developed. Here, we use a series of screens that identify these compounds as potent inducers of neurite outgrowth through a polypharmacological mechanism. Using proteomics and X-ray crystallography, we discover that these compounds extensively regulate the 14-3-3 interactome by stabilizing specific PPIs, while disrupting others. These results provide new insights into the development of drugs to target 14-3-3 PPIs, a potential therapeutic strategy for CNS diseases.Targeting protein-protein interactions (PPIs) is a promising approach in the development of drugs for many indications. 14-3-3 proteins are a family of phosphoprotein-binding molecules with critical functions in dozens of cell signaling networks. 14-3-3s are abundant in the central nervous system, and the small molecule fusicoccin-A (FC-A), a tool compound that can be used to manipulate 14-3-3 PPIs, enhances neurite outgrowth in cultured neurons. New semisynthetic FC-A derivatives with improved binding affinity for 14-3-3 complexes have recently been developed. Here, we use a series of screens that identify these compounds as potent inducers of neurite outgrowth through a polypharmacological mechanism. Using proteomics and X-ray crystallography, we discover that these compounds extensively regulate the 14-3-3 interactome by stabilizing specific PPIs, while disrupting others. These results provide new insights into the development of drugs to target 14-3-3 PPIs, a potential therapeutic strategy for CNS diseases.
Author Bisson, Nicolas
Kaplan, Andrew
Kato, Nobuo
Simas, Tristan
Banerjee, Sara L
Ottmann, Christian
Fournier, Alyson E
van Regteren Altena, Anna
Andrei, Sebastian A
Higuchi, Yusuke
Author_xml – sequence: 1
  givenname: Andrew
  surname: Kaplan
  fullname: Kaplan, Andrew
  email: andrew.kaplan@mail.mcgill.ca
  organization: Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada. Electronic address: andrew.kaplan@mail.mcgill.ca
– sequence: 2
  givenname: Sebastian A
  surname: Andrei
  fullname: Andrei, Sebastian A
  organization: Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands
– sequence: 3
  givenname: Anna
  surname: van Regteren Altena
  fullname: van Regteren Altena, Anna
  organization: Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada
– sequence: 4
  givenname: Tristan
  surname: Simas
  fullname: Simas, Tristan
  organization: Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada
– sequence: 5
  givenname: Sara L
  surname: Banerjee
  fullname: Banerjee, Sara L
  organization: Département de Biologie Moléculaire, Biochimie Médicale et Pathologie, Centre de Recherche sur le Cancer, Université Laval, Québec, QC, Canada
– sequence: 6
  givenname: Nobuo
  surname: Kato
  fullname: Kato, Nobuo
  organization: The Institute of Scientific and Industrial Research, Osaka University, Ibaraki, Osaka, Japan
– sequence: 7
  givenname: Nicolas
  surname: Bisson
  fullname: Bisson, Nicolas
  organization: Département de Biologie Moléculaire, Biochimie Médicale et Pathologie, Centre de Recherche sur le Cancer, Université Laval, Québec, QC, Canada
– sequence: 8
  givenname: Yusuke
  surname: Higuchi
  fullname: Higuchi, Yusuke
  organization: The Institute of Scientific and Industrial Research, Osaka University, Ibaraki, Osaka, Japan
– sequence: 9
  givenname: Christian
  surname: Ottmann
  fullname: Ottmann, Christian
  organization: Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands; Department of Chemistry, University of Duisburg-Essen, Essen, Germany
– sequence: 10
  givenname: Alyson E
  surname: Fournier
  fullname: Fournier, Alyson E
  email: alyson.fournier@mcgill.ca
  organization: Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, QC, Canada. Electronic address: alyson.fournier@mcgill.ca
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32220335$$D View this record in MEDLINE/PubMed
BookMark eNpNkF1LwzAYhYNMdE7_wsilN63Jm6TtLsfwYzDcQL0uafp2jaTNTFNk_96BE-RcPOfi4VycGzLpfY-EzDlLOePZw2dqWuwq610KDFjKIGWcXZApSMWThZTF5F-_ItcCAJgQakr2O--Oh1aHThvv_N4a7egOQxxDpaP1PfUNjS1SLhORCLqs9SH6QHfBR7Q9XfcRgzbRd0jfou1GpyMO9BXHYCPS7Rj3wX_H9pZcNtoNeHfmjHw8Pb6vXpLN9nm9Wm4SoziPCTKW1SqHuilEpthC5qoqtIFTap7JAlAL1aBh3BTMZHnBjap5JaDONVaZhBm5_909BP814hDLzg4GndM9-nEoQRQSeLbg7KTOz-pYdViXh2A7HY7l3znwA3QVaKs
CitedBy_id crossref_primary_10_1002_pro_4574
crossref_primary_10_1038_s41531_021_00230_6
crossref_primary_10_1016_j_chembiol_2023_05_008
crossref_primary_10_1016_j_nbd_2025_106801
crossref_primary_10_3762_bjoc_18_144
crossref_primary_10_1016_j_jmb_2024_168592
crossref_primary_10_3390_ijms23116206
crossref_primary_10_1021_jacs_3c07849
crossref_primary_10_1016_j_chembiol_2020_05_011
crossref_primary_10_1016_j_nbd_2023_106166
crossref_primary_10_1038_s41598_024_73979_4
crossref_primary_10_1021_jacs_4c11102
crossref_primary_10_1021_jacs_0c02151
crossref_primary_10_1212_WNL_0000000000213418
crossref_primary_10_1093_bib_bbac127
crossref_primary_10_1016_j_tips_2020_05_001
crossref_primary_10_1016_j_tips_2021_01_001
crossref_primary_10_1038_s41467_021_21908_8
crossref_primary_10_1002_cbic_202000761
crossref_primary_10_1016_j_chembiol_2023_04_005
crossref_primary_10_1021_jacs_3c05161
crossref_primary_10_1107_S2053230X2001122X
crossref_primary_10_3390_biom11091393
crossref_primary_10_1126_science_adx3595
ContentType Journal Article
Copyright Copyright © 2020 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: Copyright © 2020 Elsevier Ltd. All rights reserved.
DBID NPM
7X8
DOI 10.1016/j.chembiol.2020.02.010
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 2451-9448
ExternalDocumentID 32220335
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: CIHR
GroupedDBID NPM
7X8
ID FETCH-LOGICAL-c511t-e006d572df836509475b8ac2c2cd16482ea35fec01c80c6781c5d1b32d7aeb642
IEDL.DBID 7X8
ISICitedReferencesCount 29
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000542791900007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2451-9448
IngestDate Thu Jul 10 21:27:54 EDT 2025
Thu Jan 02 22:57:42 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords 14-3-3
spinal cord injury
axon
regeneration
Rap1
polypharmacology
Language English
License Copyright © 2020 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c511t-e006d572df836509475b8ac2c2cd16482ea35fec01c80c6781c5d1b32d7aeb642
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://cir.nii.ac.jp/crid/1871146592477868800
PMID 32220335
PQID 2384216910
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2384216910
pubmed_primary_32220335
PublicationCentury 2000
PublicationDate 2020-06-18
PublicationDateYYYYMMDD 2020-06-18
PublicationDate_xml – month: 06
  year: 2020
  text: 2020-06-18
  day: 18
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cell chemical biology
PublicationTitleAlternate Cell Chem Biol
PublicationYear 2020
References 32402470 - Trends Pharmacol Sci. 2020 Jul;41(7):431-433
32559498 - Cell Chem Biol. 2020 Jun 18;27(6):635-637
References_xml – reference: 32559498 - Cell Chem Biol. 2020 Jun 18;27(6):635-637
– reference: 32402470 - Trends Pharmacol Sci. 2020 Jul;41(7):431-433
Score 2.468114
Snippet Targeting protein-protein interactions (PPIs) is a promising approach in the development of drugs for many indications. 14-3-3 proteins are a family of...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 657
Title Polypharmacological Perturbation of the 14-3-3 Adaptor Protein Interactome Stimulates Neurite Outgrowth
URI https://www.ncbi.nlm.nih.gov/pubmed/32220335
https://www.proquest.com/docview/2384216910
Volume 27
WOSCitedRecordID wos000542791900007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qfPDFC97mjQi-RnNp1uxJhii-OAsq7K2kSTonrp1rJ_jvPck65osgSKFPLS3nnORc830IXVibdRjTnLCc5STqCknAz_ixP22Y41Rn1gSyibjfV4NBN2kKblUzVrnYE8NGbUvja-RX4Foi7pFd6PXkg3jWKN9dbSg0VlFLQCjjR7riQSChiwJ7fKR-HAp-uwQxjD22EaSFnAaoTkZ_jyyDh7nb-u-_baPNJrbEvbkx7KAVV-yiYVK-f02WANVeKThxU3A1WdAKLnMMUSBmERFE4J7VE8jDceIBHEYFDiVDT8ozdvipHo093ZersAf1gK_jx1k9hEy-ft1DL3e3zzf3pGFXIAaCrJo4WG9WxtzmSgQYvVhmShsOl4UcSnGnhcydocwoasCnMSMtywS3sXYZpC37aK0oC3eIcMdQC09yqSAg4y5SluVaGNeRmaHKmjY6X8gtBev1LQlduHJWpUvJtdHBXPjpZA6zkfoeEBVCHv3h7WO04XXqZ7iYOkGtHNauO0Xr5rMeVdOzYBZw7ycP38tyxSg
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Polypharmacological+Perturbation+of+the+14-3-3+Adaptor+Protein+Interactome+Stimulates+Neurite+Outgrowth&rft.jtitle=Cell+chemical+biology&rft.au=Kaplan%2C+Andrew&rft.au=Andrei%2C+Sebastian+A&rft.au=van+Regteren+Altena%2C+Anna&rft.au=Simas%2C+Tristan&rft.date=2020-06-18&rft.issn=2451-9448&rft.eissn=2451-9448&rft.volume=27&rft.issue=6&rft.spage=657&rft_id=info:doi/10.1016%2Fj.chembiol.2020.02.010&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2451-9448&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2451-9448&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2451-9448&client=summon